Onconetix Advances Another $500,000 to Realbotix Under Financing Facility
Onconetix provided Realbotix LLC an additional $500,000 for growth initiatives and working capital, bringing total facility draws to $3 million. The non-interest-bearing facility will be cancelled and discharged in full upon closing of the pending acquisition.